Phenotypic assays in yeast and zebrafish reveal drugs that rescue ATP13A2 deficiency

Article

Abstract: Mutations in ATP13A2 (PARK9) are causally linked to the rare neurodegenerative disorders Kufor-Rakeb

Palabras claves:

ATP13A2, budding yeast, drug screening, Heavy Metals, zebrafish

Autores:

Crawford A.D., Heins-Marroquin U., Jung P.P., Linster C.L., María Lorena Cordero-Maldonado

Fuentes:

scopus